CAS 20062-41-3
:3-Methyl-1,2,4-triazolo[3,4-a]phthalazine
Description:
3-Methyl-1,2,4-triazolo[3,4-a]phthalazine is a heterocyclic compound characterized by its unique triazole and phthalazine structures. This compound features a fused triazole ring, which contributes to its potential biological activity and chemical reactivity. It is typically a solid at room temperature and may exhibit moderate solubility in organic solvents, depending on the specific conditions. The presence of the methyl group enhances its lipophilicity, which can influence its interaction with biological systems. 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine is of interest in medicinal chemistry due to its potential pharmacological properties, including antimicrobial and antitumor activities. Its molecular structure allows for various functionalizations, making it a versatile scaffold in drug design. Additionally, the compound's stability and reactivity can be influenced by the presence of substituents on the triazole and phthalazine rings, which can be explored for developing new therapeutic agents. Overall, this compound represents a significant area of research in the field of organic and medicinal chemistry.
Formula:C10H8N4
InChI:InChI=1S/C10H8N4/c1-7-12-13-10-9-5-3-2-4-8(9)6-11-14(7)10/h2-6H,1H3
InChI key:InChIKey=HAADZFBBHXCGLW-UHFFFAOYSA-N
SMILES:CC=1N2C(C=3C(C=N2)=CC=CC3)=NN1
Synonyms:- 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine
- 3-Methyl-s-triazolo[3,4-a]phthalazine
- 3-Methyltriazolo[3,4-a]phthalazine
- s-Triazolo[3,4-a]phthalazine, 3-methyl-
- 1,2,4-Triazolo[3,4-a]phthalazine, 3-methyl-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
3-Methyl-[1,2,4]triazolo[3,4-a]phthalazine
CAS:Formula:C10H8N4Color and Shape:SolidMolecular weight:184.19733-Methyl-1,2,4-triazolo[3,4-a]phthalazine
CAS:Controlled ProductFormula:C10H8N4Color and Shape:NeatMolecular weight:184.23-Methyl-1,2,4-triazolo[3,4-a]phthalazine
CAS:3-Methyl-1,2,4-triazolo[3,4-a]phthalazine is a clinical pharmacology agent that can be used to study the effects of drugs on humans. This drug is metabolized in the liver by cytochrome P450 enzymes and glucuronide conjugates are produced. 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine has been shown to have dose-dependent effects on plasma concentrations in rats. It also has a terminal half life of around 5 hours in rat liver microsomes. The metabolites of this drug are formed through oxidation reactions and include 3-(methylcholanthrene) and 3-(methylnitrosourea). These metabolites can be detected by chromatography techniques.Formula:C10H8N4Purity:Min. 95%Molecular weight:184.2 g/mol



